Header cover image

Swiss (SMI) Market Analysis & Valuation

UpdatedApr 29, 2025
DataAggregated Company Financials
Companies211
  • 7D3.4%
  • 3M-3.9%
  • 1Y4.2%
  • YTD2.3%

The market is up 3.4% over the last week, with the Healthcare sector leading the way, up 4.8%. As for the past 12 months, the market is up 4.2%. Looking forward, earnings are forecast to grow by 11% annually.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Swiss Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 29 Apr 2025CHF 1.8tCHF 834.8bCHF 157.0b19.1x11.3x2.1x
Thu, 27 Mar 2025CHF 1.9tCHF 850.5bCHF 159.0b20.1x11.9x2.2x
Sat, 22 Feb 2025CHF 1.9tCHF 819.9bCHF 116.5b21.1x16.5x2.3x
Mon, 20 Jan 2025CHF 1.8tCHF 819.7bCHF 118.0b21.1x15.2x2.2x
Wed, 18 Dec 2024CHF 1.8tCHF 813.3bCHF 117.3b20.7x14.9x2.2x
Fri, 15 Nov 2024CHF 1.8tCHF 817.2bCHF 117.8b19.7x14.9x2.1x
Sun, 13 Oct 2024CHF 1.8tCHF 803.6bCHF 114.1b21.5x16x2.3x
Tue, 10 Sep 2024CHF 1.8tCHF 801.7bCHF 113.7b21.4x15.8x2.2x
Thu, 08 Aug 2024CHF 1.8tCHF 799.6bCHF 136.0b21.4x13.1x2.2x
Sat, 06 Jul 2024CHF 1.8tCHF 801.2bCHF 125.6b21.4x14.4x2.3x
Mon, 03 Jun 2024CHF 1.8tCHF 803.7bCHF 126.0b22x14.3x2.2x
Wed, 01 May 2024CHF 1.7tCHF 802.0bCHF 125.9b21.3x13.6x2.1x
Fri, 29 Mar 2024CHF 1.8tCHF 766.6bCHF 98.0b21.9x18.2x2.3x
Sun, 25 Feb 2024CHF 1.7tCHF 779.6bCHF 110.8b20.1x15.7x2.2x
Tue, 23 Jan 2024CHF 1.7tCHF 766.7bCHF 110.5b17.9x15.3x2.2x
Thu, 21 Dec 2023CHF 1.7tCHF 764.9bCHF 110.1b18.6x15.3x2.2x
Sat, 18 Nov 2023CHF 1.6tCHF 772.9bCHF 111.6b17.9x14.6x2.1x
Mon, 16 Oct 2023CHF 1.6tCHF 761.3bCHF 100.3b18.1x16.3x2.1x
Wed, 13 Sep 2023CHF 1.7tCHF 750.1bCHF 99.2b18.6x16.7x2.2x
Fri, 11 Aug 2023CHF 1.7tCHF 742.7bCHF 75.1b18.5x22.4x2.3x
Sun, 09 Jul 2023CHF 1.7tCHF 755.7bCHF 76.7b18.9x21.8x2.2x
Tue, 06 Jun 2023CHF 1.7tCHF 787.5bCHF 82.6b19x21.2x2.2x
Thu, 04 May 2023CHF 1.8tCHF 784.0bCHF 80.7b19.5x21.9x2.3x
Sat, 01 Apr 2023CHF 1.7tCHF 780.5bCHF 69.3b19.5x25.1x2.2x
Mon, 27 Feb 2023CHF 1.7tCHF 783.7bCHF 71.4b18.9x24.1x2.2x
Wed, 25 Jan 2023CHF 1.8tCHF 786.7bCHF 94.0b17.8x19x2.3x
Fri, 23 Dec 2022CHF 1.7tCHF 788.3bCHF 94.1b17.5x17.8x2.1x
Sun, 20 Nov 2022CHF 1.7tCHF 792.5bCHF 95.5b17.6x17.9x2.2x
Tue, 18 Oct 2022CHF 1.6tCHF 801.9bCHF 103.8b16.5x15.5x2x
Thu, 15 Sep 2022CHF 1.7tCHF 789.8bCHF 102.0b17.9x16.5x2.1x
Sat, 13 Aug 2022CHF 1.8tCHF 808.8bCHF 102.1b17.7x17.3x2.2x
Mon, 11 Jul 2022CHF 1.7tCHF 805.2bCHF 106.2b17x16.3x2.2x
Wed, 08 Jun 2022CHF 1.8tCHF 807.2bCHF 106.1b18.2x17x2.2x
Fri, 06 May 2022CHF 1.9tCHF 806.3bCHF 106.7b18x17.5x2.3x
Price to Earnings Ratio

17.5x


Total Market Cap: CHF 1.9tTotal Earnings: CHF 106.7bTotal Revenue: CHF 806.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Market Price to Earnings3Y Average 17.1x202320242025
Current Market PE
  • Investors are pessimistic on the Swiss market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 11.3x which is lower than its 3-year average PE of 17.1x.
Past Earnings Growth
  • The earnings for Swiss listed companies have grown 14% per year over the last three years, while revenues have remained steady.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Sector Trends

Which sectors have driven the changes within the Swiss Market?

CH Market3.41%
Consumer Discretionary7.32%
Tech5.19%
Healthcare4.77%
Materials4.48%
Industrials3.76%
Financials3.43%
Utilities2.05%
Telecom1.33%
Real Estate1.21%
Consumer Staples-1.29%
Sector PE
  • Investors favour the Consumer Discretionary sector the most for future growth, which is trading above its 3-year average PE ratio of 23.8x.
    • Analysts expect its future annual earnings growth (13.6%) to be largely in line with prior year's earnings growth.
    • The market's confidence could indicate that the market believes that analysts are underestimating future growth.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 19% over the next 5 years.
  • However this is lower than its past earnings growth rate of 35% per year.
  • In contrast, the Real Estate sector is expected to see its earnings decline by 4.3% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
ROG Roche HoldingCHF 265.103.7%
+CHF 7.6b
19.8%PE25.5xHealthcare
CFR Compagnie Financière RichemontCHF 147.257.6%
+CHF 6.1b
13.5%PE27.3xConsumer Discretionary
NOVN NovartisCHF 93.403.1%
+CHF 5.3b
5.1%PE18.1xHealthcare
GALD Galderma GroupCHF 93.3018.8%
+CHF 3.5b
36.6%PE116.8xHealthcare
UBSG UBS GroupCHF 24.978.6%
+CHF 3.3b
-0.5%PE18.3xFinancials
See more
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Market Insights

The term ‘ Fiscal Dominance ’ has been popping up more in recent years, thanks to rising U.S. deficits. For the sake of your portfolio, this trend and its consequences are worth knowing about.

Latest News

UBSG

CHF 24.97

UBS Group

7D

8.6%

1Y

-0.5%

CFR

CHF 147.25

Compagnie Financière Richemont

7D

7.6%

1Y

13.5%

CMBN

CHF 97.75

Cembra Money Bank

7D

-2.4%

1Y

38.5%

ABBN

CHF 43.39

ABB

7D

2.8%

1Y

-4.2%

LLBN

CHF 75.30

Liechtensteinische Landesbank

7D

-2.1%

1Y

6.8%

BARN

CHF 736.00

Barry Callebaut

7D

-2.9%

1Y

-46.9%

GALD

CHF 93.30

Galderma Group

7D

18.8%

1Y

36.6%

ROG

CHF 265.10

Roche Holding

7D

3.7%

1Y

19.8%

NOVN

CHF 93.40

Novartis

7D

3.1%

1Y

5.1%

BLKB

CHF 882.00

Basellandschaftliche Kantonalbank

7D

-2.6%

1Y

1.6%